Basic Information
Orionis Biosciences is an early-stage drug discovery and development biotechnology company with a range of disruptive technologies that can drive the development of innovative drugs for treating diseases with highly unmet medical needs, initially focusing internally on oncology and immunotherapy.
Orionis Biosciences, LLC.
Massachusetts,United States of America
15~50 people
January 01, 2015
press@orionisbio.com

